BONESUPPORT's Technology to be Featured in Clinical Program at American Academy of Orthopaedic Surgeons Meeting in Chicago
BOSTON, March 21, 2022 /PRNewswire-PRWeb/ --Today, BONESUPPORT , innovator of injectable bone grafts that change the standard of care for patients with bone infections, is announcing plans to exhibit at The American Academy of Orthopaedic Surgeons Meeting in Chicago on March 22-26 with its platform technology CERAMENT, being featured in the Clinical Program.
- BOSTON, March 21, 2022 /PRNewswire-PRWeb/ --Today, BONESUPPORT , innovator of injectable bone grafts that change the standard of care for patients with bone infections, is announcing plans to exhibit at The American Academy of Orthopaedic Surgeons Meeting in Chicago on March 22-26 with its platform technology CERAMENT, being featured in the Clinical Program.
- BONESUPPORT (Nasdaq Stockholm: BONEX) Holding AB (publ), is the innovator of injectable bone grafts that change the standard of care for patients with bone infections.
- Based on the patented technology, CERAMENTTM, and backed by robust clinical evidence, BONESUPPORT delivers the first injectable combination bone substitute that promotes and protects bone healing.
- The company is based in Lund, Sweden and has secured FDA authorization for CERAMENT G in the U.S.